Literature DB >> 15193886

Microspheres of corn protein, zein, for an ivermectin drug delivery system.

Xinming Liu1, Qingshen Sun, Huajie Wang, Lei Zhang, J-Y Jin-Ye Wang.   

Abstract

A novel microsphere drug delivery system of ivermectin (IVM) using hydrophobic protein zein was prepared by the phase separation method and characterized by a scanning electron microscope and laser light scattering particle size analyzer. Releases of model drug IVM from zein microspheres, tabletted microspheres and pepsin degradation of tabletted microspheres were also performed in vitro to investigate the mechanism of model drug release. The results show that the zein microspheres and tabletted microspheres are suitable for use as a sustained-release form of IVM. The microspheres may also be useful in drug targeting system since the diameter of the microspheres is appropriate for phagocytosis by macrophages. Moreover, the release of IVM from enzymatic degraded tabletted microspheres shows a zero-order release, implying a potential application in tissue engineering for preparing scaffold, which is composed of microspheres encapsulating bioactive components for stimulating cell differentiation and proliferation. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15193886     DOI: 10.1016/j.biomaterials.2004.02.013

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  46 in total

1.  Development and characterization of zein-based microcarrier system for sustained delivery of aceclofenac sodium.

Authors:  K Karthikeyan; Rachita Lakra; Rama Rajaram; Purna Sai Korrapati
Journal:  AAPS PharmSciTech       Date:  2011-12-14       Impact factor: 3.246

2.  The biodegradation of zein in vitro and in vivo and its application in implants.

Authors:  Teng Lin; Chuanhua Lu; Ligen Zhu; Tao Lu
Journal:  AAPS PharmSciTech       Date:  2010-12-24       Impact factor: 3.246

3.  Dental mold: a novel formulation to treat common dental disorders.

Authors:  Soma Ghosh; Gopa Roy; Biswajit Mukherjee
Journal:  AAPS PharmSciTech       Date:  2009-05-23       Impact factor: 3.246

4.  Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery.

Authors:  Eric Farris; Deborah M Brown; Amanda E Ramer-Tait; Angela K Pannier
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

5.  Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration.

Authors:  Firas Bassissi; Anne Lespine; Michel Alvinerie
Journal:  Parasitol Res       Date:  2005-12-10       Impact factor: 2.289

6.  Zein/polycaprolactone electrospun matrices for localised controlled delivery of tetracycline.

Authors:  Nour Alhusein; Ian S Blagbrough; Paul A De Bank
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

7.  The Development of Direct Extrusion-Injection Moulded Zein Matrices as Novel Oral Controlled Drug Delivery Systems.

Authors:  Jacob Bouman; Peter Belton; Paul Venema; Erik van der Linden; Renko de Vries; Sheng Qi
Journal:  Pharm Res       Date:  2015-03-17       Impact factor: 4.200

Review 8.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

9.  Chemical Characterization and Release of Polyphenols from Pecan Nut Shell [Carya illinoinensis (Wangenh) C. Koch] in Zein Microparticles for Bioactive Applications.

Authors:  Itamara Kureck; Priscila de Brito Policarpi; Isabela Maia Toaldo; Matheus Vinícius de Oliveira Brisola Maciel; Marilde T Bordignon-Luiz; Pedro Luiz Manique Barreto; Jane Mara Block
Journal:  Plant Foods Hum Nutr       Date:  2018-06       Impact factor: 3.921

Review 10.  Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.

Authors:  Hedieh Malekzad; Hamed Mirshekari; Parham Sahandi Zangabad; S M Moosavi Basri; Fazel Baniasadi; Maryam Sharifi Aghdam; Mahdi Karimi; Michael R Hamblin
Journal:  Crit Rev Biotechnol       Date:  2017-04-24       Impact factor: 8.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.